Synthesis, biological evaluation, X-ray structure, and pharmacokinetics of aminopyrimidine c-jun-N-terminal kinase (JNK) inhibitors.

Journal of Medicinal Chemistry
Ted KameneckaPhilip V LoGrasso

Abstract

Given the significant body of data supporting an essential role for c-jun-N-terminal kinase (JNK) in neurodegenerative disorders, we set out to develop highly selective JNK inhibitors with good cell potency and good brain penetration properties. The structure-activity relationships (SAR) around a series of aminopyrimidines were evaluated utilizing biochemical and cell-based assays to measure JNK inhibition and brain penetration in mice. Microsomal stability in three species, P450 inhibition, inhibition of generation of reactive oxygen species (ROS), and pharmacokinetics in rats were also measured. Compounds 9g, 9i, 9j, and 9l had greater than 135-fold selectivity over p38, and cell-based IC(50) values < 100 nM. Moreover, compound 9l showed an IC(50) = 0.8 nM for inhibition of ROS and had good pharmacokinetic properties in rats along with a brain-to-plasma ratio of 0.75. These results suggest that biaryl substituted aminopyrimidines represented by compound 9l may serve as the first small molecule inhibitors to test efficacy of JNK inhibitors in neurodegenerative disorders.

References

Mar 7, 1998·The Journal of Biological Chemistry·Y LuoG S Roth
Jan 5, 2000·The Journal of Biological Chemistry·S KharbandaD Kufe
Aug 16, 2001·Proceedings of the National Academy of Sciences of the United States of America·X G XiaJ B Schulz
Jun 20, 2002·Journal of Immunological Methods·James F CurtinThomas G Cotter
Jan 31, 2003·Proteins·Simon C LovellDavid C Richardson
Jan 6, 2004·Proceedings of the National Academy of Sciences of the United States of America·Stéphane HunotRichard A Flavell
May 25, 2004·The Journal of Biological Chemistry·Jun PengJulie K Andersen
Sep 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·UNKNOWN Collaborative Computational Project, Number 4
May 1, 1997·Acta Crystallographica. Section D, Biological Crystallography·G N MurshudovE J Dodson
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
Apr 29, 2005·Journal of Medicinal Chemistry·Yvonne C Martin
Jul 13, 2005·The Journal of Cell Biology·Jun SunayamaYukiko Gotoh
Sep 6, 2005·Bioorganic & Medicinal Chemistry Letters·Britt-Marie SwahnLiselotte Ohberg
Dec 13, 2005·Bioorganic & Medicinal Chemistry Letters·Britt-Marie SwahnJenny Viklund
Dec 28, 2005·Current Medicinal Chemistry·Matthew R Lee, Celia Dominguez
Jun 9, 2006·Journal of Medicinal Chemistry·Bruce G SzczepankiewiczJames M Trevillyan
Oct 26, 2006·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Grisha PirianovHuseyin Mehmet
Dec 30, 2006·Bioorganic & Medicinal Chemistry Letters·Richard M AngellRuolan Wang
Apr 27, 2007·Bioorganic & Medicinal Chemistry Letters·Mahbub AlamLaura J Tait
Oct 4, 2007·Bioorganic & Medicinal Chemistry Letters·Rong JiangTheodore M Kamenecka
Aug 5, 2008·Mini Reviews in Medicinal Chemistry·Philip LoGrasso, Theodore Kamenecka
Mar 31, 2009·Bioorganic & Medicinal Chemistry Letters·Paul S HumphriesDavid M Wilhite
Aug 1, 2007·Journal of Applied Crystallography·Airlie J McCoyRandy J Read
Jan 1, 1997·Methods in Enzymology·Zbyszek Otwinowski, Wladek Minor

❮ Previous
Next ❯

Citations

Dec 22, 2012·The Journal of Biological Chemistry·Jeremy W ChambersPhilip V LoGrasso
Apr 12, 2013·Future Medicinal Chemistry·Piotr P Graczyk
May 21, 2015·Expert Opinion on Therapeutic Patents·Matthias GehringerStefan A Laufer
Jan 28, 2015·Scientific Reports·HaJeung ParkPhilip LoGrasso
Jul 1, 2011·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Stéphane SengmanyEric Léonel
Apr 18, 2014·Nature Reviews. Neuroscience·Eleanor T Coffey
Jan 19, 2012·British Journal of Pharmacology·Joost C M UitdehaagGuido J R Zaman
May 24, 2014·Organic & Biomolecular Chemistry·Karothu Durga PrasadTayur N Guru Row
Oct 15, 2013·British Journal of Pharmacology·Concetta Bubici, Salvatore Papa
Apr 8, 2020·Cells·Manel B HammoudaJennifer Y Zhang
Jan 8, 2020·International Journal of Molecular Sciences·Oriol BusquetsAntoni Camins
Jul 9, 2020·Computational and Structural Biotechnology Journal·Men Thi Hoai DuongHee-Chul Ahn
May 1, 2021·International Journal of Molecular Sciences·Stephanie Cristine Hepp RehfeldtMárcia Inês Goettert
Apr 22, 2015·ACS Medicinal Chemistry Letters·Ke ZhengYangbo Feng
Nov 22, 2014·Journal of Medicinal Chemistry·Pierre KochStefan A Laufer
Nov 13, 2012·Structure·John D LaughlinPhilip V LoGrasso
Oct 19, 2011·Bioorganic & Medicinal Chemistry Letters·Xinyi SongTheodore M Kamenecka
Nov 13, 2012·Bioorganic & Medicinal Chemistry Letters·Leyi GongDavid Goldstein

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.